With its purchase of ViraTherapeutics, German’s Boehringer Ingelheim joins a large and growing list of Big Pharma companies investing in viruses that are engineered to seek out and destroy cancer.
BI Joins Pharma Frenzy For Cancer-Killing Viruses With $244M Acquisition
